de Scordilli, M.; Michelotti, A.; Bertoli, E.; De Carlo, E.; Del Conte, A.; Bearz, A.
Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials. Int. J. Mol. Sci. 2022, 23, 7222.
https://doi.org/10.3390/ijms23137222
AMA Style
de Scordilli M, Michelotti A, Bertoli E, De Carlo E, Del Conte A, Bearz A.
Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials. International Journal of Molecular Sciences. 2022; 23(13):7222.
https://doi.org/10.3390/ijms23137222
Chicago/Turabian Style
de Scordilli, Marco, Anna Michelotti, Elisa Bertoli, Elisa De Carlo, Alessandro Del Conte, and Alessandra Bearz.
2022. "Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials" International Journal of Molecular Sciences 23, no. 13: 7222.
https://doi.org/10.3390/ijms23137222
APA Style
de Scordilli, M., Michelotti, A., Bertoli, E., De Carlo, E., Del Conte, A., & Bearz, A.
(2022). Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials. International Journal of Molecular Sciences, 23(13), 7222.
https://doi.org/10.3390/ijms23137222
